Polen Capital acquired 6.33 Thousand Charles River Laboratories International shares worth $1.7 Million. That's 0.00% of their equity portfolio (94th largest holding). The first Charles River Laboratories International trade was made in Q2 2022. Since then Polen Capital bought shares three more times and sold shares on three occasions. The stake costed the investor $1.46 Million, netting the investor a gain of 16% so far.
Charles River Laboratories (CRL) has sold its Avian Vaccine Services business to private equity firm Arlington Capital Partners.The business, now AVS Bio, wi...
Seeking Alpha, about 1 year agoZero NPLs on Rs. 14 Billion worth loans in a globally challenging year Colombo, June 30, 2021 Softlogic Finance PLC, a subsidiary of Softlogic Capital the f...
Lanka Business News, over 2 years ago